Basal ganglia volumes in patients with Gilles de la Tourette syndrome

Archives of General Psychiatry

Volumn 60, Issue 4, 2003, Pages 415-424

  Peterson, Bradley S ^a,b   Thomas, Prakash ^b   Kane, Michael J ^a   Scahill, Lawrence ^b   Zhang, Heping ^c   Bronen, Richard ^c   King, Robert A ^b   Leckman, James F ^b   Staib, Lawrence ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FUNCTIONAL ANATOMY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; OPTICAL RESOLUTION; PATHOPHYSIOLOGY; STATISTICAL ANALYSIS; STRUCTURE ANALYSIS; SYMPTOMATOLOGY; TISSUE SPECIFICITY;

ADOLESCENT; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASAL GANGLIA; BRAIN; CAUDATE NUCLEUS; CHILD; COMORBIDITY; FEMALE; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PUTAMEN; TOURETTE SYNDROME;

EID: 0344838617     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.4.415     Document Type: Article

References (53)

1. Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 1989;46:722-730.
2. Peterson BS. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J Clin Psychiatry. 1996;57(suppl 9):24-34.
3. MacLean PD, Delgado JMR. Electrical and chemical stimulation of frontotemporal portion of limbic system in the waking animal. Electroencephalogr Clin Neurophysiol. 1953;5:91-100.
4. Baldwin M, Frost LL, Wood CD. Investigation of the primate amygdala: movements of the face and laws. Neurology. 1954;4:596-598.
5. Sweet RD, Bruun R, Shapiro E, Shapiro AK. Presynaptic catecholamine antagonists as treatment for Tourette syndrome: effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry. 1974;31:857-861.
6. Jankovic J, Glaze DG, Frost J Jr. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology. 1984;34:688-692.
7. Kelley AE, Lang CG, Gauthier AM. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology. 1988;95:556-559.
8. Peterson BS, Leckman JF, Arnsten A, Anderson G, Staib L, Gore J, Bronen R, Malison R, Scahill L, Cohen D. Neuroanatomical circuitry. In: Leckman JF, Cohen DJ, eds. Tourette's Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York, NY: John Wiley & Sons Inc; 1999:230-259.
9. Peterson BS, Riddle MA, Cohen DJ, Katz LD, Smith JC, Hardin MT, Leckman JF. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology. 1993;43:941-949.
10. Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E, Harris EL, Reader MJ, Chase GA, Bryan RN, Denckla MB. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology. 1993;43:950-956.
11. Hyde TM, Aaronson BA, Randolph C, Weinberger DR. Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology. 1995;45:1176-1182.
12. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology. 1997;49:410-415.
13. Castellanos FX, Giedd JN, Hamburger SD, Marsh WL, Rapoport JL. Brain morphometry in Tourette's syndrome: the influence of comorbid attention-deficit/hyperactivity disorder. Neurology. 1996;47:1581-1583.
14. Peterson B, Klein J. Neuroimaging of Tourette's syndrome neurobiologic substrate. In: Peterson BS, ed. Child Psychiatry Clinics of North America: Neuroimaging. Vol 6. Philadelphia, Pa: WB Saunders Co; 1997:343-364.
15. Peterson BS, Thomas P. Functional brain imaging in Tourette's syndrome: what are we really imaging? In: Ernst M, Rumsey J, eds. Functional Neuroimaging in Child Psychiatry. Cambridge, Mass: Cambridge University Press; 2000:242-265.
16. Peterson BS. Neuroimaging studies of Tourette syndrome: a decade of progress. In: Cohen DJ, Goetz CG, Jankovic J, eds. Advances in Neurology: Tourette Syndrome and Associated Disorders. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:179-196.
17. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9:97-113.
18. Pauls DL, Hurst CR. Schedule for Tourette and Other Behavioral Syndromes. New Haven, Conn: Yale University Child Study Center; revised March 1993 and March 1996.
19. Ambrosini PJ, Metz C, Pradbucki K, Lee J. Videotape reliability of the third revised edition of the K-SADS. JAm Acad Child Adolesc Psychiatry. 1989;28:723-728.
20. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
21. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978;35:837-844.
22. Leckman JF, Sholomskas D, Thompson D, Belanger A, Weissman M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry. 1982;39:879-883.
23. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566-573.
24. Goodman WK, Price LH, Rasmusson SA, Mazure C, Delgado P, Henninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
25. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844-852.
26. DuPaul G J. Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychology. 1991;20:245-253.
27. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-428.
28. Naugle RI, Chelune GJ, Tucker GD. Validity of the Kaufman Brief Intelligence Test. Psychol Assess. 1993;5:182-186.
29. Grossman I, Kaufman AS, Grossman D. Correlations of scores on the Kaufman short neuropsychological assessment procedure and the Kaufman Adolescent and Adult Intelligence Test for a hospitalized depressed sample. Percept Mot Skills. 1993;77:1055-1058.
30. Wechsler D. WAIS-R Manual: Wechsler Adult Intelligence Scale - Revised. San Antonio, Tex: Psychological Corp; 1981.
31. Hollingshead AB. Four-Factor Index of Social Status. New Haven, Conn: Yale University Press; 1975.
32. Peterson BS, Leckman JF, Tucker D, Scahill L, Staib L, Zhang H, King R, Cohen DJ, Gore JC, Lombroso P. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in chronic tic, obsessive-compulsive, and attention deficit-hyperactivity disorder. Arch Gen Psychiatry. 2000;57:364-372.
33. Clarke LP, Velthuizen RP, Camacho MA, Heine JJ, Vaidyanathan M, Hall LO, Thatcher RW, Silbiger ML. MRI segmentation: methods and applications. Magn Reson Imaging. 1995;13:343-368.
34. Morrell CH, Pearson JD, Brant LJ. Linear transformations of linear mixed-effects models. Am Stat. 1997;51:338-343.
35. Peterson BS, Cohen DJ. The treatment of Tourette's syndrome: a multimodal developmental intervention. J Clin Psychiatry. 1998;59(suppl 1):62-72.
36. Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, Leckman JF, Gore JC. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry. 1998;55:326-333.
37. Pauls DL, Raymond CL, Stevenson JM, Leckman JF. A family study of Gilles de la Tourette syndrome. Am J Hum Genet. 1991;48:154-163.
38. Hasstedt SJ, Leppert M, Filloux F, van de Weterin BJM, McMahon WM. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet. 1995;57:682-689.
39. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Gen. 1996;59:684-693.
40. Leckman JF, Dolnansky ES, Hardin MT, Clubb M, Walkup JT, Stevenson J, Pauls DL. Perinatal factors in the expression of Tourette's syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry. 1990;29:220-226.
41. Peterson BS, Leckman JF, Lombroso P, Zhang H, Lynch K, Carter A, Pauls D, Cohen D. Environmental risk and protective factors. In: Leckman JF, Cohen DJ, eds. Tourette's Syndrome - Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York, NY: John Wiley & Sons Inc; 1999:213-228.
42. Peterson BS, Leckman JF, Cohen DJ. Tourette's syndrome: a genetically predisposed and an environmentally specified developmental psychopathology. In: Cicchetti D, Cohen DJ, eds. Developmental Psychopathology. Vol 2. New York, NY: John Wiley & Sons Inc; 1995:213-242.
43. Goetz CG, Tanner CM, Stebbins GT, Leipzig G, Carr WC. Adult tics in Gilles de la Tourette's syndrome: description and risk factors. Neurology. 1992;42:784-788.
44. Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim Y-S, Peterson BS. Course of tic severity in Tourette's syndrome: the first two decades. Pediatrics. 1998;102:14-19.
45. Peterson BS, Pine DS, Cohen P, Brook J. A prospective, longitudinal study of tic, obsessive-compulsive, and attention deficit-hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry. 2001;40:685-695.
46. Burd L, Kerbeshian PJ, Barth A, Klug MG, Avery PK, Benz B. Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J Child Neurol. 2001;16:431-437.
47. Peterson BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF, Cohen DJ, Gore JC, Albert J, Webster R Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry. 2001;58:427-440.
48. Alexander G, Crutcher M, DeLong M. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal," and "limbic" functions. Prog Brain Res. 1990;85:119-146.
49. Parent A, Hazrati LN. Functional anatomy of the basal ganglia, I: the corticobasal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev. 1995;20:91-127.
50. Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, Lenane MC, McKenna K, Breier A, Rapoport JL. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry. 1996;153:564-566.
51. Corson PW, Nopoulos P, Miller DD, Arndt S, Andreasen NC. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry. 1999;156:1200-1204.
52. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry. 1998;155:1711-1717.
53. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Honer WG. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry. 2001;158:625-631.